Enthesitis and ankylosis in spondyloarthropathy: What is the target of the immune response?
Open Access
- 1 December 2000
- journal article
- abstracts
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 59 (12) , 985-994
- https://doi.org/10.1136/ard.59.12.985
Abstract
A report from a symposium held at Klinikum Benjamin Franklin, Free University, Berlin, Germany, 25–26 February 2000 This symposium was organised by J Braun and J Sieper (Free University, Berlin) to review the current knowledge of the anatomical, inflammatory, microbiological, and immunological events in enthesitis. The term “enthesopathy” is relatively new and its medical history short, but some important contributions can be listed (boxFB1). Figure FB1 History of “enthesopathy” • 1966 Enthesopathy first used by Niepel • 1970 Entheses centrally affected in ankylosing spondylitis, in contrast with rheumatoid arthritis (RA; Heberden oration lecture by Ball) • 1975 Some enthesitis in sacroiliitis (François) • 1983 Syndrome of seronegative enthesopathy and arthropathy in children (Rosenberg) • 1982 Sacroiliitis starts in the subchondral bone (Shichikawa) • 1991 Enthesopathy discriminative feature of spondyloarthropathy (SpA; European Spondyloarthropathy Study Group criteria, Dougados) • 1998 Entheses more commonly affected in arthritis in SpA compared with RA (McGonagle) The spondyloarthropathies are among the most common inflammatory rheumatic diseases.1 In addition to the strong genetic predisposition, partly due to HLA-B27,2 there are characteristic clinical features of SpA3: inflammatory back pain often due to sacroiliitis4 and enthesitis occurring mostly at various well defined locations, predominantly of the legs, such as the Achilles tendon, the plantar aponeurosis, the knee, the trochanter regions of the femur, and several pelvic sites.5 Thus entheses are ubiquitous, resulting in a diversity of associated pathological manifestations. Sacroiliitis is the most common early sign of SpA.6Whether or not ligamentous and entheseal structures are affected in sacroiliac inflammation has not yet been entirely clarified. To answer some of the most critical questions an expert symposium on enthesitis was organised:Keywords
This publication has 53 references indexed in Scilit:
- Vascular Endothelial Growth Factor Is Expressed in Human Fetal Growth CartilageJournal of Bone and Mineral Research, 2000
- Isolation and characteristics of autoreactive T cells specific to aggrecan G1 domain from rheumatoid arthritis patientsCell Research, 2000
- Classification of inflammatory arthritis by enthesitisThe Lancet, 1998
- Regional differences in cell shape and gap junction expression in rat Achilles tendon: relation to fibrocartilage differentiationJournal of Anatomy, 1998
- Arthritis induced by proteoglycan aggrecan G1 domain in BALB/c mice. Evidence for t cell involvement and the immunosuppressive influence of keratan sulfate on recognition of t and b cell epitopes.Journal of Clinical Investigation, 1998
- Transgenic Mice Expressing a TruncatedPeromyscus leucopusTNF-α Gene Manifest an Arthritis Resembling Ankylosing SpondylitisJournal of Interferon & Cytokine Research, 1998
- Cartilage-Derived Morphogenetic Proteins and Osteogenic Protein-1 Differentially Regulate OsteogenesisJournal of Bone and Mineral Research, 1998
- A human chondrodysplasia due to a mutation in a TGF-β superfamily memberNature Genetics, 1996
- Immunity to the G1 globular domain of the cartilage proteoglycan aggrecan can induce inflammatory erosive polyarthritis and spondylitis in BALB/c mice but immunity to G1 is inhibited by covalently bound keratan sulfate in vitro and in vivo.Journal of Clinical Investigation, 1996
- HLA-B27 as a relative risk factor in ankylosing enthesopathy in transgenic miceHuman Immunology, 1995